| Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy R Silva, V Vilas-Boas, H Carmo, RJ Dinis-Oliveira, F Carvalho, ... Pharmacology & therapeutics 149, 1-123, 2015 | 401 | 2015 |
| Green synthesis of fluorescent carbon dots from spices for in vitro imaging and tumour cell growth inhibition N Vasimalai, V Vilas-Boas, J Gallo, M de Fátima Cerqueira, ... Beilstein journal of nanotechnology 9 (1), 530-544, 2018 | 202 | 2018 |
| Magnetic hyperthermia for cancer treatment: Main parameters affecting the outcome of in vitro and in vivo studies V Vilas-Boas, F Carvalho, B Espiña Molecules 25 (12), 2874, 2020 | 103 | 2020 |
| Biocompatibility and bioimaging potential of fruit-based carbon dots C Dias, N Vasimalai, M P. Sárria, I Pinheiro, V Vilas-Boas, J Peixoto, ... Nanomaterials 9 (2), 199, 2019 | 87 | 2019 |
| Interaction of polyacrylic acid coated and non-coated iron oxide nanoparticles with human neutrophils D Couto, M Freitas, V Vilas-Boas, I Dias, G Porto, MA Lopez-Quintela, ... Toxicology letters 225 (1), 57-65, 2014 | 66 | 2014 |
| Performance enhanced UV/vis spectroscopic microfluidic sensor for ascorbic acid quantification in human blood H Bi, CM Duarte, M Brito, V Vilas-Boas, S Cardoso, P Freitas Biosensors and Bioelectronics 85, 568-572, 2016 | 54 | 2016 |
| The mixture of “ecstasy” and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations DJ Barbosa, JP Capela, R Silva, V Vilas-Boas, LM Ferreira, PS Branco, ... Archives of toxicology 88, 455-473, 2014 | 52 | 2014 |
| Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier event LG Rossato, VM Costa, V Vilas-Boas, M de Lourdes Bastos, A Rolo, ... Cardiovascular toxicology 13, 413-425, 2013 | 51 | 2013 |
| Cocaine-induced kidney toxicity: an in vitro study using primary cultured human proximal tubular epithelial cells MJ Valente, R Henrique, V Vilas-Boas, R Silva, ML Bastos, F Carvalho, ... Archives of toxicology 86, 249-261, 2012 | 48 | 2012 |
| Mechanisms and in vitro models of drug-induced cholestasis E Gijbels, V Vilas-Boas, N Deferm, L Devisscher, H Jaeschke, P Annaert, ... Archives of toxicology 93, 1169-1186, 2019 | 47 | 2019 |
| Colchicine effect on P-glycoprotein expression and activity: In silico and in vitro studies R Silva, H Carmo, V Vilas-Boas, DJ Barbosa, A Palmeira, E Sousa, ... Chemico-biological interactions 218, 50-62, 2014 | 42 | 2014 |
| Portable sensing system based on electrochemical impedance spectroscopy for the simultaneous quantification of free and total microcystin-LR in freshwaters MB Dos Santos, RB Queirós, Á Geraldes, C Marques, V Vilas-Boas, ... Biosensors and Bioelectronics 142, 111550, 2019 | 41 | 2019 |
| Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury E Gijbels, V Vilas‐Boas, P Annaert, T Vanhaecke, L Devisscher, M Vinken Archives of Toxicology 94, 1151-1172, 2020 | 40 | 2020 |
| Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1, 8-dibenzoyl-rifampicin V Vilas-Boas, R Silva, C Nunes, S Reis, L Ferreira, C Vieira, F Carvalho, ... Toxicology Letters 220 (3), 259-266, 2013 | 40 | 2013 |
| Hepatotoxicity induced by nanomaterials: mechanisms and in vitro models V Vilas-Boas, M Vinken Archives of toxicology 95 (1), 27-52, 2021 | 37 | 2021 |
| Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition V Vilas-Boas, E Gijbels, J Jonckheer, E De Waele, M Vinken Environment international 136, 105422, 2020 | 35 | 2020 |
| P‐glycoprotein activity in human Caucasian male lymphocytes does not follow its increased expression during aging V Vilas‐Boas, R Silva, AR Gaio, AM Martins, SC Lima, ... Cytometry Part A 79 (11), 912-919, 2011 | 34 | 2011 |
| Development of Novel Rifampicin-Derived P-Glycoprotein Activators/Inducers. Synthesis V Vilas-Boas, R Silva, A Palmeira, E Sousa, LM Ferreira, PS Branco, ... PLoS ONE 8 (8), e74425, 2013 | 32 | 2013 |
| Primary hepatocytes and their cultures for the testing of drug-induced liver injury V Vilas-Boas, A Cooreman, E Gijbels, R Van Campenhout, E Gustafson, ... Advances in Pharmacology 85, 1-30, 2019 | 27 | 2019 |
| Doxorubicin decreases paraquat accumulation and toxicity in Caco-2 cells R Silva, H Carmo, V Vilas-Boas, PG de Pinho, RJ Dinis-Oliveira, ... Toxicology Letters 217 (1), 34-41, 2013 | 27 | 2013 |